How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: SIEMENS HEALTHINEERS · Firm: FARRAGUT PARTNERS LLP
Issues related to HR6197 and HR4299 (patient access)
Protecting Patient Access to Cancer and Complex Therapies Act
Client: GENENTECH · Firm: FARRAGUT PARTNERS LLP
Issues related to legislation relating to the 340B drug discount program. Also, legislation relating to Medicare physician payments, including H.R. 4299. Issues relating to GLOBE/GUARD
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
COMCAST CORPORATION via FARRAGUT PARTNERS LLP
2026 · third_quarter · 3A
Privacy issues relating to the gathering, retention, and use of online information.
Spectrum Reform. Cyber security. Program carriage. Rural Broadband Infrastructure. Privacy Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| COX ENTERPRISES, INC |
| 45 |
| 2016–2026 |
| GENENTECH | 45 | 2016–2026 |
| JOHNSON & JOHNSON SERVICES, INC. | 45 | 2016–2026 |
| NATIONAL CABLE AND TELECOMMUNICATIONS ASSOCIATION | 45 | 2016–2026 |
| SOUTHERN COMPANY | 45 | 2016–2026 |
| AT&T SERVICES, INC. | 44 | 2017–2026 |
| GILEAD SCIENCES, INC. | 44 | 2017–2026 |
| EDWARDS LIFESCIENCES LLC | 42 | 2017–2026 |
| LIVE NATION ENTERTAINMENT | 39 | 2017–2025 |
| OMEGA FLEX | 34 | 2016–2023 |
| DAIICHI SANKYO INC | 28 | 2018–2026 |
| ONEONCOLOGY INC. | 28 | 2020–2026 |
| SPR THERAPEUTICS | 26 | 2021–2026 |
| DTE ENERGY | 25 | 2021–2026 |
| AMBULATORY SURGERY CENTER ASSOCIATION | 24 | 2017–2022 |
| ORGANIZE ACTION NETWORK | 23 | 2022–2026 |
| SANCTUARY SYSTEMS | 23 | 2021–2026 |
| AMERICAN OPTOMETRIC ASSOCIATION | 22 | 2016–2021 |
| CAREVISO (FORMERLY KNOWN AS CMT SOLUTIONS) | 22 | 2020–2025 |
| SPECTRUM PHARMACEUTICALS, INC | 22 | 2018–2023 |
| U.S. WOMEN'S HEALTH ALLIANCE | 22 | 2021–2026 |
| BLUE CROSS AND BLUE SHIELD ASSOCIATION | 21 | 2016–2020 |
| LANTHEUS MEDICAL IMAGING, INC. | 21 | 2022–2026 |
| ANIMAL WELLNESS ACTION | 20 | 2022–2026 |
| DIRECTV | 20 | 2022–2026 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 20 | 2022–2026 |
| ELISABETH POTTER MD PLLC | 19 | 2022–2026 |
| NOVAVAX, INC. | 19 | 2020–2024 |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | 17 | 2017–2020 |
| BeyondSpring Inc. | 17 | 2021–2024 |
| NANTWORKS | 17 | 2020–2023 |
| ULTIMATE FIGHTING CHAMPIONSHIP | 17 | 2016–2019 |
| AMERICAN INDEPENDENT MEDICAL PRACTICE ASSOCIATION | 14 | 2023–2026 |
| IDEVELOPMENT AND ECONOMIC ASSOCIATION | 14 | 2019–2022 |
| AMAG PHARMACEUTICALS, INC. | 13 | 2020–2022 |
| ASTRAZENECA PHARMACEUTICALS LP | 13 | 2017–2019 |
| CHARTER BROKERAGE | 13 | 2023–2025 |
| CTIA-THE WIRELESS ASSOCIATION | 13 | 2017–2019 |
| PATIENTPOINT | 13 | 2024–2026 |
| ILLUMINA | 12 | 2023–2025 |
| THE WILLIAMS COMPANIES | 12 | 2016–2018 |
| DEXCOM INC | 10 | 2024–2026 |
| PAIR TEAM | 10 | 2025–2026 |
| PATCHRX | 10 | 2023–2025 |
| PHARMACOSMOS THERAPEUTICS INC. | 10 | 2024–2026 |
| UNITED TECHNOLOGIES CORPORATION | 10 | 2016–2018 |
| CYTOKINETICS INC | 9 | 2024–2026 |
| ELECTROCORE | 9 | 2020–2022 |
| GUADALUPE BLANCO RIVER AUTHORITY | 9 | 2018–2019 |
| NEURAL FEDERAL INC | 9 | 2025–2026 |
| NEXTERA ENERGY INC | 9 | 2016–2018 |
| PERSONALIZED CANCER THERAPY, INC. | 9 | 2016–2017 |
| ALTRIA CLIENT SERVICES LLC | 8 | 2016–2017 |
| Assertio Holdings, Inc. | 8 | 2023–2025 |
| BTG INTERNATIONAL INC. | 8 | 2025–2026 |
| CONNECT HOLDING LLC | 8 | 2021–2023 |
| DIGESTIVE HEALTH PHYSICIANS ASSOCIATION | 8 | 2025–2026 |
| ENTERPRISE MOBILITY | 8 | 2025–2026 |
| FULLSCRIPT | 8 | 2025–2026 |
| SOUNDEXCHANGE | 8 | 2017–2018 |
| NEURALACE MEDICAL, INC. | 7 | 2025–2026 |
| PRESERVATION RANCH, LLC | 7 | 2019–2020 |
| RTW USA LLC | 7 | 2019–2020 |
| TECHNET THE VOICE OF INNOVATION ECONOMY | 7 | 2025–2026 |
| AMERISOURCEBERGEN CORPORATION | 6 | 2016–2017 |
| BRIDGEBIO | 6 | 2025–2026 |
| FAMILIES AGAINST MANDATORY MINIMUMS | 6 | 2021–2022 |
| GLOBE METALLURGICAL | 6 | 2017–2018 |
| INTUITY MEDICAL | 6 | 2023–2024 |
| La Jolla Pharmaceutical Company | 6 | 2020–2021 |
| RSBIX CO. | 6 | 2020–2022 |
| SLIDE TO SAFETY | 6 | 2016–2017 |
| HYDROMINE, INC. | 5 | 2018–2019 |
| IFRAH LAW PLLC | 5 | 2019 |
| LIFE CONNECTION OF OHIO | 5 | 2025–2026 |
| MEDTAG, LLC | 5 | 2017–2018 |
| PROTEUS DIGITAL HEALTH, INC. | 5 | 2019 |
| REPLIMUNE | 5 | 2025–2026 |
| STEELRIVER INFRASTRUCTURE PARTNERS | 5 | 2017–2018 |
| SWIFT SOLAR INC | 5 | 2020–2021 |
| UNIQURE INC. | 5 | 2025–2026 |
| ALLIED OMS | 4 | 2026 |
| ENERGY FUTURE HOLDINGS | 4 | 2016 |
| EVERMORE | 4 | 2026 |
| PIERRE FABRE PHARMACEUTICALS, INC. | 4 | 2026 |
| SALUDA MEDICAL | 4 | 2025–2026 |
| TAKEDA PHARMACEUTICALS AMERICA INC | 4 | 2026 |
| CARDIOVASCULAR ASSOCIATES OF AMERICA | 3 | 2026 |
| HELSINN THERAPEUTICS | 3 | 2019 |
| PACT COALITION | 3 | 2026 |
| SC3 INTERNATIONAL LLC | 3 | 2020 |
| SIEMENS HEALTHINEERS | 3 | 2026 |
| SYMPHONY ASSET MANAGEMENT LLC | 3 | 2020 |
| TRIO HEALTH REGULATORY ADVISORY GROUP, LLC | 3 | 2021 |
Protecting Patient Access to Cancer and Complex Therapies Act
Client: GENENTECH · Firm: FARRAGUT PARTNERS LLP
Issues related to legislation relating to the 340B drug discount program. Also, legislation relating to Medicare physician payments, including H.R. 4299. Issues relating to GLOBE/GUARD
Protecting Patient Access to Cancer and Complex Therapies Act
Client: PACT COALITION · Firm: FARRAGUT PARTNERS LLP
Issues related to HR 4299
Protecting Patient Access to Cancer and Complex Therapies Act
Client: TAKEDA PHARMACEUTICALS AMERICA INC · Firm: FARRAGUT PARTNERS LLP
Issues relating to HR 4299 and other heath issues.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: PACT COALITION · Firm: FARRAGUT PARTNERS LLP
Issues related to HR 4299
Protecting Patient Access to Cancer and Complex Therapies Act
Client: TAKEDA PHARMACEUTICALS AMERICA INC · Firm: FARRAGUT PARTNERS LLP
Issues relating to HR 4299, Protecting Patients' Access to Cancer and Complex Therapies Act, and general healthcare
To amend the National Housing Act to direct the Secretary of Housing and Urban Development to establish a program to insure certain second liens secured against property for the purpose of financing the construction of an accessory dwelling unit, and for other purposes.
Client: LANTHEUS MEDICAL IMAGING, INC. · Firm: FARRAGUT PARTNERS LLP
Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)
To amend the National Housing Act to direct the Secretary of Housing and Urban Development to establish a program to insure certain second liens secured against property for the purpose of financing the construction of an accessory dwelling unit, and for other purposes.
Client: LANTHEUS MEDICAL IMAGING, INC. · Firm: FARRAGUT PARTNERS LLP
Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)
To amend the National Housing Act to direct the Secretary of Housing and Urban Development to establish a program to insure certain second liens secured against property for the purpose of financing the construction of an accessory dwelling unit, and for other purposes.
Client: LANTHEUS MEDICAL IMAGING, INC. · Firm: FARRAGUT PARTNERS LLP
Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)
Issues related to HR6197 and HR4299 (patient access)
Issues related to physician reimbursement, AI policy, radiation oncology cuts and HR 6197 Health Tech Investment Act
Issues related to physician reimbursement, AI policy, radiation oncology cuts and HR 6197 Health Tech Investment Act
Issues related to vehicle data access Electric Vehicles/Electric Vehicle Infrastructure Vehicle Data Access Issues H.R. 6687 DRIVER Act
Issues related to vehicle data access Electric Vehicles/Electric Vehicle Infrastructure Vehicle Data Access Issues H.R. 6687 DRIVER Act
Issues related to vehicle data access Electric Vehicles/Electric Vehicle Infrastructure Vehicle Data Access Issues H.R. 6687 DRIVER Act
To designate the facility of the United States Postal Service located at 2600 Michigan Avenue in Kissimmee, Florida, as the "Robert Guevara Post Office Building".
Client: TAKEDA PHARMACEUTICALS AMERICA INC · Firm: FARRAGUT PARTNERS LLP
Issues relating to HR 7299 and other heath issues.
To designate the facility of the United States Postal Service located at 2600 Michigan Avenue in Kissimmee, Florida, as the "Robert Guevara Post Office Building".
Client: TAKEDA PHARMACEUTICALS AMERICA INC · Firm: FARRAGUT PARTNERS LLP
Issues relating to HR 7299 and other heath issues.
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
Financial Technology Protection Act of 2025
Client: LANTHEUS MEDICAL IMAGING, INC. · Firm: FARRAGUT PARTNERS LLP
Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)
Financial Technology Protection Act of 2025
Client: LANTHEUS MEDICAL IMAGING, INC. · Firm: FARRAGUT PARTNERS LLP
Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)
Financial Technology Protection Act of 2025
Client: LANTHEUS MEDICAL IMAGING, INC. · Firm: FARRAGUT PARTNERS LLP
Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)
Issues relating to S.985 Protect USA Act of 2025 Ongoing EU trade issues
Issues relating to S.985 Protect USA Act of 2025 Ongoing EU trade issues
Issues relating to S.985 Protect USA Act of 2025 Ongoing EU trade issues
Tax Relief for American Families and Workers Act of 2024
Client: DIRECTV · Firm: FARRAGUT PARTNERS LLP
Issues related to H.R.7024 Tax Relief for American Families and Workers Act of 2024
Tax Relief for American Families and Workers Act of 2024
Client: DIRECTV · Firm: FARRAGUT PARTNERS LLP
Issues related to H.R.7024 Tax Relief for American Families and Workers Act of 2024
Tax Relief for American Families and Workers Act of 2024
Client: DIRECTV · Firm: FARRAGUT PARTNERS LLP
Issues related to H.R.7024 Tax Relief for American Families and Workers Act of 2024
issues related the 1992 Cable Act. FCC Draft NPRM on MDU Bulk Billing. FCC NPRM on broadcast blackouts. S. 4207 The Spectrum and National Security Act
issues related the 1992 Cable Act. FCC Draft NPRM on MDU Bulk Billing. FCC NPRM on broadcast blackouts. S. 4207 The Spectrum and National Security Act
issues related the 1992 Cable Act. FCC Draft NPRM on MDU Bulk Billing. FCC NPRM on broadcast blackouts. S. 4207 The Spectrum and National Security Act
Issues related to S.5579, Auto Data Privacy and Autonomy Act.
Issues related to S.5579, Auto Data Privacy and Autonomy Act.
Issues related to S.5579, Auto Data Privacy and Autonomy Act.
Work related to passage of the FDA Modernization Act of 2021 (S. 2952) (H.R. 2565)
Work related to passage of the FDA Modernization Act of 2021 (S. 2952) (H.R. 2565)
Work related to passage of the FDA Modernization Act of 2021 (S. 2952) (H.R. 2565)
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
Work related to passage of the FDA Modernization Act of 2021 (S. 2952) (H.R. 2565)
Work related to passage of the FDA Modernization Act of 2021 (S. 2952) (H.R. 2565)
Work related to passage of the FDA Modernization Act of 2021 (S. 2952) (H.R. 2565)
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
To amend the National Housing Act to direct the Secretary of Housing and Urban Development to establish a program to insure certain second liens secured against property for the purpose of financing the construction of an accessory dwelling unit, and for other purposes.
Client: LANTHEUS MEDICAL IMAGING, INC. · Firm: FARRAGUT PARTNERS LLP
Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)
To amend the National Housing Act to direct the Secretary of Housing and Urban Development to establish a program to insure certain second liens secured against property for the purpose of financing the construction of an accessory dwelling unit, and for other purposes.
Client: LANTHEUS MEDICAL IMAGING, INC. · Firm: FARRAGUT PARTNERS LLP
Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)
To amend the National Housing Act to direct the Secretary of Housing and Urban Development to establish a program to insure certain second liens secured against property for the purpose of financing the construction of an accessory dwelling unit, and for other purposes.
Client: LANTHEUS MEDICAL IMAGING, INC. · Firm: FARRAGUT PARTNERS LLP
Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)
To amend the National Housing Act to direct the Secretary of Housing and Urban Development to establish a program to insure certain second liens secured against property for the purpose of financing the construction of an accessory dwelling unit, and for other purposes.
Client: LANTHEUS MEDICAL IMAGING, INC. · Firm: FARRAGUT PARTNERS LLP
Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)
To amend the National Housing Act to direct the Secretary of Housing and Urban Development to establish a program to insure certain second liens secured against property for the purpose of financing the construction of an accessory dwelling unit, and for other purposes.
Client: LANTHEUS MEDICAL IMAGING, INC. · Firm: FARRAGUT PARTNERS LLP
Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)
Freedom from Automated Speed Enforcement Act of 2025
Client: PATCHRX · Firm: FARRAGUT PARTNERS LLP
Issues related to remote therapeutic monitoring; work on HR 5394
Freedom from Automated Speed Enforcement Act of 2025
Client: PATCHRX · Firm: FARRAGUT PARTNERS LLP
Issues related to remote therapeutic monitoring; work on HR 5394
Freedom from Automated Speed Enforcement Act of 2025
Client: PATCHRX · Firm: FARRAGUT PARTNERS LLP
Issues related to remote therapeutic monitoring; work on HR 5394
Issues related to vehicle data access Electric Vehicles/Electric Vehicle Infrastructure Vehicle Data Access Issues H.R. 6687 DRIVER Act
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
Financial Technology Protection Act of 2025
Client: LANTHEUS MEDICAL IMAGING, INC. · Firm: FARRAGUT PARTNERS LLP
Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)
Financial Technology Protection Act of 2025
Client: LANTHEUS MEDICAL IMAGING, INC. · Firm: FARRAGUT PARTNERS LLP
Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)
Financial Technology Protection Act of 2025
Client: LANTHEUS MEDICAL IMAGING, INC. · Firm: FARRAGUT PARTNERS LLP
Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)
Financial Technology Protection Act of 2025
Client: LANTHEUS MEDICAL IMAGING, INC. · Firm: FARRAGUT PARTNERS LLP
Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)
Financial Technology Protection Act of 2025
Client: LANTHEUS MEDICAL IMAGING, INC. · Firm: FARRAGUT PARTNERS LLP
Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)
Issues relating to S.985 Protect USA Act of 2025 Ongoing EU trade issues
Tax Relief for American Families and Workers Act of 2024
Client: DIRECTV · Firm: FARRAGUT PARTNERS LLP
Issues related to H.R.7024 Tax Relief for American Families and Workers Act of 2024
Tax Relief for American Families and Workers Act of 2024
Client: DIRECTV · Firm: FARRAGUT PARTNERS LLP
Issues related to H.R.7024 Tax Relief for American Families and Workers Act of 2024
Tax Relief for American Families and Workers Act of 2024
Client: DIRECTV · Firm: FARRAGUT PARTNERS LLP
Issues related to H.R.7024 Tax Relief for American Families and Workers Act of 2024
Tax Relief for American Families and Workers Act of 2024
Client: DIRECTV · Firm: FARRAGUT PARTNERS LLP
Issues related to H.R.7024 Tax Relief for American Families and Workers Act of 2024
issues related the 1992 Cable Act. FCC Draft NPRM on MDU Bulk Billing. FCC NPRM on broadcast blackouts. S. 4207 The Spectrum and National Security Act
issues related the 1992 Cable Act. FCC Draft NPRM on MDU Bulk Billing. FCC NPRM on broadcast blackouts. S. 4207 The Spectrum and National Security Act
issues related the 1992 Cable Act. FCC Draft NPRM on MDU Bulk Billing. FCC NPRM on broadcast blackouts. S. 4207 The Spectrum and National Security Act
issues related the 1992 Cable Act. FCC Draft NPRM on MDU Bulk Billing. FCC NPRM on broadcast blackouts. S. 4207 The Spectrum and National Security Act
Issues related to S.5579, Auto Data Privacy and Autonomy Act.
Work related to passage of the FDA Modernization Act of 2021 (S. 2952) (H.R. 2565)
Work related to passage of the FDA Modernization Act of 2021 (S. 2952) (H.R. 2565)
Work related to passage of the FDA Modernization Act of 2021 (S. 2952) (H.R. 2565)
Work related to passage of the FDA Modernization Act of 2021 (S. 2952) (H.R. 2565)
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
Work related to passage of the FDA Modernization Act of 2021 (S. 2952) (H.R. 2565)
Work related to passage of the FDA Modernization Act of 2021 (S. 2952) (H.R. 2565)
Work related to passage of the FDA Modernization Act of 2021 (S. 2952) (H.R. 2565)
Work related to passage of the FDA Modernization Act of 2021 (S. 2952) (H.R. 2565)
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
Positioning the Election Assistance Commission for the Future Act of 2023
Client: LANTHEUS MEDICAL IMAGING, INC. · Firm: FARRAGUT PARTNERS LLP
Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)
Positioning the Election Assistance Commission for the Future Act of 2023
Client: LANTHEUS MEDICAL IMAGING, INC. · Firm: FARRAGUT PARTNERS LLP
Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)
Positioning the Election Assistance Commission for the Future Act of 2023
Client: LANTHEUS MEDICAL IMAGING, INC. · Firm: FARRAGUT PARTNERS LLP
Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)
Positioning the Election Assistance Commission for the Future Act of 2023
Client: LANTHEUS MEDICAL IMAGING, INC. · Firm: FARRAGUT PARTNERS LLP
Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)
Issues related to remote therapeutic monitoring; work on HR 5394
Issues related to remote therapeutic monitoring; work on HR 5394
Issues related to remote therapeutic monitoring; work on HR 5394
Issues related to remote therapeutic monitoring; work on HR 5394
2026 · third_quarter · Q3
Issues related to cardiac PET scans
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERASTEM ONCOLOGY via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to FDA approval of oncology drugs and drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AGILIX HEALTH via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Agilix issues relating to nutrional and dietary policies, CMS remote therapeutic monitoring codes, public health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AGILENT TECHNOLOGIES, INC. via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to healthcare tariffs, supply chain, and taxes
Issues related to healthcare tariffs, supply chain, and taxes
Issues related to healthcare tariffs, supply chain, and taxes
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TAKEDA PHARMACEUTICALS AMERICA INC via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues relating to HR 4299 and other heath issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PACT COALITION via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to HR 4299
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CARDIOVASCULAR ASSOCIATES OF AMERICA via FARRAGUT PARTNERS LLP
2026 · third_quarter · 3T
Issues related to cardiac PET scans
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SIEMENS HEALTHINEERS via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to physician reimbursement, AI policy, radiation oncology cuts and HR 6197 Health Tech Investment Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EVERMORE via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to the Supplemental Nutrition Assistance Program (SNAP) program
Issues related to the Supplemental Nutrition Assistance Program (SNAP) program
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
ALLIED OMS via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to VCA agreements for oral surgery
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PIERRE FABRE PHARMACEUTICALS, INC. via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to FDA coverage of Tabelecucel
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFE CONNECTION OF OHIO via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues pertaining to OPO reforms and general organ procurement issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIQURE INC. via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to FDA review of AMT-130
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIDGEBIO via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
issues related to drug coverage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FULLSCRIPT via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to wellness and whole-person care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TECHNET THE VOICE OF INNOVATION ECONOMY via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to federal privacy legislation and other.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEURALACE MEDICAL, INC. via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to medicare coverage of mPNS therapy devices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEURAL FEDERAL INC via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to population health
Monitoring AI issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENTERPRISE MOBILITY via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to Airport related issues
Issues related to Corporate and international tax reform proposals Tax incentives for electric vehicles and electric vehicle charging infrastructure Issues related to the One Big Beautiful Bill Act (P.L. 119-21)
Issues relating to S.985 Protect USA Act of 2025 Ongoing EU trade issues
BTG INTERNATIONAL INC. via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to national stock pile and bio defense
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PAIR TEAM via FARRAGUT PARTNERS LLP
2026 · third_quarter · 3T
General health care issues. Issues related to patient medication adherence and quality issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Medicare physician payment reform, site neutrality and access colorectal cancer screenings
Issues related to gastroenterologists healthcare providers, general healthcare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACOSMOS THERAPEUTICS INC. via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
General representation and issues related to coverage of treatments for chemotherapy induced iron deficiency anemia and chemotherapy induced Myelosuppression. Safe Step Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYTOKINETICS INC. via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
General healthcare representation. Monitoring relevant healthcare legislative and regulatory activity.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DEXCOM, INC. via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
General representation. Legislative and regulatory issues related to policies and payments for continuous glucose monitoring
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENTPOINT via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to medication adherence and population health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORGANIZE ACTION NETWORK via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to the organ donation system and the organ procurement transplantation network.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
AMERICAN INDEPENDENT MEDICAL PRACTICE ASSOCIATION via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues pertaining to healthcare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELISABETH POTTER MD PLLC via FARRAGUT PARTNERS LLP
2026 · third_quarter · 3T
Issues related to coverage policy for Medicare reimbursement of breast reconstruction surgery
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIRECTV via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to H.R.7024 Tax Relief for American Families and Workers Act of 2024
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information.
ANIMAL WELLNESS ACTION via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Work related to passage of the FDA Modernization Act of 2021 (S. 2952) (H.R. 2565)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
General representation. Regulations and legislation relating to PBMs and drug pricing. Issues related to the 340B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LANTHEUS MEDICAL IMAGING, INC. via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
U.S. WOMEN'S HEALTH ALLIANCE via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to OB/GYN healthcare providers. Issues relating to alternative payment models. Issues relating to maternal health
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
SPR THERAPEUTICS via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to coverage of peripheral nerve stimulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
DTE ENERGY via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
general representation related to the power grid, energy efficiency and climate change
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ONEONCOLOGY LLC via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. Monitoring CMMI Demonstration Projects. CON regulations. CARES implementation.
Issues related to pharmacy benefit managers.
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. Monitoring CMMI Demonstration Projects. CON regulations. CARES implementation
DAIICHI SANKYO INC via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues relating to the coverage of treatments for iron deficiency anemia
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC. via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues pertaining to the 340B drug discount program.
Coverage and reimbursement policy for HCV and HIV portfolios. Issues pertaining to the six protected classes. Drug pricing legislation- part D redesign. Issues related to Medicaid drug rebate program. Monitoring CMMI demonstrations
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EDWARDS LIFESCIENCES, LLC via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Coverage and reimbursement policy for medical devices/THV Medicare coverage of breakthrough therapies Policies promoting medical innovation. Coverage with evidence development.
21st Century Cures 2.0
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AT&T SERVICES INC via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Copyright, communications and consumer protection
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMCAST CORPORATION via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Net Neutrality. Spectrum Reform. Cyber security. Program carriage. Rural Broadband Infrastructure. Privacy Issues
Privacy issues relating to the gathering, retention, and use of online information.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HERON THERAPEUTICS, INC. via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to non-opioid alternatives reimbursement. Coverage decisions related to anti nausea treatments. Federal non-opioid directive legislation
Issues related to non-opioid alternatives reimbursement. Coverage decisions related to anti nausea treatments. Federal non-opioid directive legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOUTHERN COMPANY via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues affecting the regulation of greenhouse gas emissions from power plants and other air and solid waste issues affecting power plant operations
Issues affecting the regulation of greenhouse gas emissions from power plants and other air and solid waste issues affecting power plant operations. Issues affecting federal regulation of electricity transmission, including planning and cost allocation
Issues affecting the regulation of greenhouse gas emissions from power plants and other air and solid waste issues affecting power plant operations.
T-MOBILE ASSOCIATION via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
lobbying activities specific to wireless policy on consumer protection and privacy issues in the House and Senate Commerce and Judiciary Committees; general lobbying spectrum related issues, including FCC's incentive auctions; lobbying activities related to acquiring additional spectrum for commercial use before the House and Senate Armed Services Committees. Broadband infrastructure issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COX ENTERPRISES, INC via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Legislation related to autonomous issues and legislation related to automotive safety
Legislation related to rewriting the Telecommunications act of 1934. Privacy issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMMUNITY ONCOLOGY ALLIANCE via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Legislation regarding the 340B Drug discount program. Issues related to pharmacy benefit managers. Drug Pricing legislation. 21st Century Cures 2.0
Issues related to pharmacy benefit managers. TACT Act
Issues pertaining to Medicare reimbursement. Legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI demonstration (OCM/OCF)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENENTECH via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to legislation relating to the 340B drug discount program. Also, legislation relating to Medicare physician payments, including H.R. 4299. Issues relating to GLOBE/GUARD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHNSON & JOHNSON SERVICES INC via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to the 340B drug discount program. Medicare Part B. Biosimilar Legislation. Drug pricing legislation. Issues related to ASP reporting. Issues related to patient safety in attorney advertising. Vaccine coverage issues. Maternal health legislation.
Issues related to the 340B drug discount program. Medicare Part B. Biosimilar Legislation. Drug pricing legislation. Issues related to ASP reporting. Issues related to patient safety in attorney advertising. Vaccine coverage issues. Maternal health legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL CABLE AND TELECOMMUNICATIONS ASSOCIATION via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Privacy and Behavioral Advertising issues relating to the gathering, retention, and use of online information. Program access, Net neutrality, spectrum reform and reallocation, broadband deployment issues including use of stimulus finds for rural broadband deployment and adoption and broadband conduit legislation. National Broadband Plan issues relating to competition and innovation in navigation devices
Privacy and Behavioral Advertising issues relating to the gathering, retention, and use of online information. Program access, Net neutrality, spectrum reform and reallocation, broadband deployment issues including use of stimulus finds for rural broadband deployment and adoption and broadband conduit legislation. National Broadband Plan issues relating to competition and innovation in navigation devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
Issues pertaining to Medicare reimbursement. Issues pertaining to Medicare coverage decisions. Issues related to ambulatory surgery centers. Opioid and prescription drug monitoring programs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
21ST CENTURY PRIVACY COALITION via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues pertaining to data security and privacy
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Telecommunications & Information Administration (NTIA), SENATE
CARDIAC PET ALLIANCE via FARRAGUT PARTNERS LLP
2026 · third_quarter · RR
Issues related to cardiac PET scans
VERASTEM ONCOLOGY via FARRAGUT PARTNERS LLP
2026 · third_quarter · RR
Issues related to FDA approval of oncology drugs and drug pricing
AGILIX HEALTH via FARRAGUT PARTNERS LLP
2026 · third_quarter · RR
Issues relating to nutritional and dietary policies
SILFAB SOLAR via FARRAGUT PARTNERS LLP
2026 · third_quarter · RR
Issues related to Section 232 polysilicon tariffs
AGILENT TECHNOLOGIES, INC. via FARRAGUT PARTNERS LLP
2026 · third_quarter · RR
Issues related to healthcare tariffs, supply chain, and taxes
Issues related to healthcare tariffs, supply chain, and taxes
Issues related to healthcare tariffs, supply chain, and taxes
AT&T SERVICES INC via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Copyright, communications and consumer protection
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TAKEDA PHARMACEUTICALS AMERICA INC via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues relating to HR 7299 and other heath issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PACT COALITION via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to HR 4299
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CARDIOVASCULAR ASSOCIATES OF AMERICA via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to cardiac PET scans
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SIEMENS HEALTHINEERS via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to physician reimbursement, AI policy, radiation oncology cuts and HR 6197 Health Tech Investment Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EVERMORE via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to the Supplemental Nutrition Assistance Program (SNAP) program
Issues related to the Supplemental Nutrition Assistance Program (SNAP) program
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
ALLIED OMS via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to VCA agreements for oral surgery
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PIERRE FABRE PHARMACEUTICALS, INC. via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to FDA coverage of Tabelecucel
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFE CONNECTION OF OHIO via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues pertaining to OPO reforms and general organ procurement issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIQURE INC. via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to FDA review of AMT-130
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SALUDA MEDICAL via FARRAGUT PARTNERS LLP
2026 · second_quarter · 2T
Issues related to spinal cord stimulation and healthcare access issues
Issues related to spinal cord stimulation and healthcare access issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPLIMUNE via FARRAGUT PARTNERS LLP
2026 · first_quarter · 1T
issues related to advanced melanoma cancer treatments
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
BRIDGEBIO via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
issues related to drug coverage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FULLSCRIPT via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to wellness and whole-person care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TECHNET THE VOICE OF INNOVATION ECONOMY via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to federal privacy legislation and other.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEURALACE MEDICAL, INC. via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to medicare coverage of mPNS therapy devices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEURAL FEDERAL INC via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to population health
Monitoring AI issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENTERPRISE MOBILITY via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
issues related to Commuter Vanpool/Transit Funding Issues Transportation reauthorization
Issues related to S.5579, Auto Data Privacy and Autonomy Act.
Issues related to vehicle data access Electric Vehicles/Electric Vehicle Infrastructure Vehicle Data Access Issues H.R. 6687 DRIVER Act
BTG INTERNATIONAL INC. via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to national stock pile and bio defense
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PAIR TEAM via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
General health care issues. Issues related to patient medication adherence and quality issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PAIR TEAM via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
General health care issues. Issues related to patient medication adherence and quality issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to gastroenterologists healthcare providers, general healthcare
Medicare physician payment reform, site neutrality and access colorectal cancer screenings
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACOSMOS THERAPEUTICS INC. via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
General representation and issues related to coverage of treatments for chemotherapy induced iron deficiency anemia and chemotherapy induced Myelosuppression
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYTOKINETICS INC. via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
General healthcare representation. Monitoring relevant healthcare legislative and regulatory activity.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DEXCOM, INC. via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
General representation. Legislative and regulatory issues related to policies and payments for continuous glucose monitoring
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENTPOINT via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to medication adherence and population health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORGANIZE ACTION NETWORK via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to the organ donation system and the organ procurement transplantation network.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
AMERICAN INDEPENDENT MEDICAL PRACTICE ASSOCIATION via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues pertaining to healthcare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELISABETH POTTER MD PLLC via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to coverage policy for Medicare reimbursement of breast reconstruction surgery
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIRECTV via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. Issues related to privacy and childrens online safety and related legislation including S. 3663, the Kids Online Safety Act and H.R. 8152, the American Data Privacy and Protection Act. H.R. 8188, the American Privacy Rights Act and other privacy legislation.
issues related the 1992 Cable Act. FCC Draft NPRM on MDU Bulk Billing. FCC NPRM on broadcast blackouts. S. 4207 The Spectrum and National Security Act
ANIMAL WELLNESS ACTION via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Work related to passage of the FDA Modernization Act of 2021 (S. 2952) (H.R. 2565)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
General representation. Regulations and legislation relating to PBMs and drug pricing. Issues related to the 340B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LANTHEUS MEDICAL IMAGING, INC. via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
U.S. WOMEN'S HEALTH ALLIANCE via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to OB/GYN healthcare providers. Issues relating to alternative payment models. Issues relating to maternal health
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
SANCTUARY SYSTEMS via FARRAGUT PARTNERS LLP
2026 · second_quarter · 2T
Issues related to the production of US based manufacturing of medical grade face masks
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
SPR THERAPEUTICS via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to coverage of peripheral nerve stimulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
DTE ENERGY via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
general representation related to the power grid, energy efficiency and climate change
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ONEONCOLOGY LLC via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. Monitoring CMMI Demonstration Projects. CON regulations. CARES implementation
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. Monitoring CMMI Demonstration Projects. CON regulations. CARES implementation.
DAIICHI SANKYO INC via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues relating to the coverage of treatments for iron deficiency anemia
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC. via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Coverage and reimbursement policy for HCV and HIV portfolios. Issues pertaining to the six protected classes. Drug pricing legislation- part D redesign. Issues related to Medicaid drug rebate program. Monitoring CMMI demonstrations
Issues pertaining to the 340B drug discount program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EDWARDS LIFESCIENCES, LLC via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Coverage and reimbursement policy for medical devices/THV Medicare coverage of breakthrough therapies Policies promoting medical innovation. Coverage with evidence development.
21st Century Cures 2.0
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMCAST CORPORATION via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Net Neutrality. Spectrum Reform. Cyber security. Program carriage. Rural Broadband Infrastructure. Privacy Issues
Privacy issues relating to the gathering, retention, and use of online information.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to vehicle data access Electric Vehicles/Electric Vehicle Infrastructure Vehicle Data Access Issues H.R. 6687 DRIVER Act
issues related to Commuter Vanpool/Transit Funding Issues Transportation reauthorization
Issues related to electric vehicles; Issues related to P.L. 119-16 - Providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "California State Motor Vehicle and Engine Pollution Control Standards; Advanced Clean Cars II; Waiver of Preemption; Notice of Decision."
Issues related to S.5579, Auto Data Privacy and Autonomy Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related the 1992 Cable Act
issues related the 1992 Cable Act. FCC Draft NPRM on MDU Bulk Billing. FCC NPRM on broadcast blackouts. S. 4207 The Spectrum and National Security Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues affecting the regulation of greenhouse gas emissions from power plants and other air and solid waste issues affecting power plant operations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Corporate and international tax reform proposals Tax incentives for electric vehicles and electric vehicle charging infrastructure Issues related to the One Big Beautiful Bill Act (P.L. 119-21)
Issues relating to S.985 Protect USA Act of 2025 Ongoing EU trade issues
Issues related to Airport related issues
Issues related to electric vehicles; Issues related to P.L. 119-16 - Providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "California State Motor Vehicle and Engine Pollution Control Standards; Advanced Clean Cars II; Waiver of Preemption; Notice of Decision."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information.
Issues related the 1992 Cable Act
Issues related to H.R.7024 Tax Relief for American Families and Workers Act of 2024
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to pharmacy benefit managers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE